相似文献
1
New Strategies to Combat Human Fungal Infections.
J Fungi (Basel). 2024 Dec 18;10(12):880. doi: 10.3390/jof10120880.
2
Exploring the Arsenal of Novel Antifungal Drug Targets for Combating Fungal Infections.
Curr Pharm Biotechnol. 2024 Sep 13. doi: 10.2174/0113892010304880240828075411.
3
Prevalence and Healthcare Burden of Fungal Infections in the United States, 2018.
Open Forum Infect Dis. 2022 Jan 10;9(1):ofab593. doi: 10.1093/ofid/ofab593. eCollection 2022 Jan.
4
Antifungals discovery: an insight into new strategies to combat antifungal resistance.
Lett Appl Microbiol. 2018 Jan;66(1):2-13. doi: 10.1111/lam.12820. Epub 2017 Dec 11.
5
Invasive Fungal Diseases of Combat Wounds: Burden, Epidemiology, and Mycology.
Mycopathologia. 2024 Nov 21;189(6):102. doi: 10.1007/s11046-024-00908-4.
6
Comparative genomics allowed the identification of drug targets against human fungal pathogens.
BMC Genomics. 2011 Jan 27;12:75. doi: 10.1186/1471-2164-12-75.
7
Strategies to Prevent Cardiac Implantable Electronic Device Infection.
J Innov Card Rhythm Manag. 2020 Jan 15;11(1):3949-3956. doi: 10.19102/icrm.2020.110102. eCollection 2020 Jan.
8
From Biology to Drug Development: New Approaches to Combat the Threat of Fungal Biofilms.
Microbiol Spectr. 2015 Jun;3(3). doi: 10.1128/microbiolspec.MB-0007-2014.
9
Molecular mechanism of host-yeast interactions and prevention by nanoformulation approaches.
Microb Pathog. 2025 Aug;205:107663. doi: 10.1016/j.micpath.2025.107663. Epub 2025 May 6.
10
Antifungal resistance, combinations and pipeline: oh my!
Drugs Context. 2023 Nov 9;12. doi: 10.7573/dic.2023-7-1. eCollection 2023.
本文引用的文献
1
Invasive fungal disease in the immunocompromised host: changing epidemiology, new antifungal therapies, and management challenges.
Clin Microbiol Infect. 2025 Jan;31(1):29-36. doi: 10.1016/j.cmi.2024.08.006. Epub 2024 Aug 12.
2
Oral Isavuconazole Combined with Nebulized Inhalation and Bronchoscopic Administration of Amphotericin B for the Treatment of Pulmonary Mucormycosis: A Case Report and Literature Review.
J Fungi (Basel). 2024 May 29;10(6):388. doi: 10.3390/jof10060388.
3
Amphotericin B in the Era of New Antifungals: Where Will It Stand?
J Fungi (Basel). 2024 Apr 10;10(4):278. doi: 10.3390/jof10040278.
4
Molecular Pathway, Epidemiological Data and Treatment Strategies of Fungal Infection (Mycoses): A Comprehensive Review.
Cent Nerv Syst Agents Med Chem. 2024;24(1):68-81. doi: 10.2174/0118715249274215231205062701.
5
Advancements and challenges in antifungal therapeutic development.
Clin Microbiol Rev. 2024 Mar 14;37(1):e0014223. doi: 10.1128/cmr.00142-23. Epub 2024 Jan 31.
6
Global incidence and mortality of severe fungal disease.
Lancet Infect Dis. 2024 Jul;24(7):e428-e438. doi: 10.1016/S1473-3099(23)00692-8. Epub 2024 Jan 12.
7
Antifungal Activity of Chitosan against in Planktonic and Biofilm Forms: A Therapeutic Strategy in the Future?
J Fungi (Basel). 2023 Dec 15;9(12):1201. doi: 10.3390/jof9121201.
8
Regulatory Ability of on Human Skin Health by Counteracting In Vitro Effects.
J Fungi (Basel). 2023 Nov 29;9(12):1153. doi: 10.3390/jof9121153.
9
The Influence of Medium Composition on EUCAST and Etest Antifungal Susceptibility Testing.
J Fungi (Basel). 2023 Sep 27;9(10):973. doi: 10.3390/jof9100973.
10
Cyclosporine Affects the Main Virulence Factors of In Vitro.
J Fungi (Basel). 2023 Apr 18;9(4):487. doi: 10.3390/jof9040487.
Zotero 插件